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Background: To support better headache management in primary care, the Global Campaign against Headache
developed an 8-question outcome measure, the Headache Under-Response to Treatment (HURT) questionnaire.
HURT was designed by an expert consensus group with patient-input. It assesses the need for and response to
treatment, and provides guidance on actions to optimize therapy. It has proven content validity.
We aim to evaluate the Arabic version of HURT for clinical utility in primary care in Saudi Arabia.
Methods: HURT was translated according to the Global Campaign’s translation protocol. We assessed test-retest
reliability in consecutive patients of four primary-care centres, who completed HURT at two visits 4-6 weeks apart
while receiving usual care. We then provided training in headache management to the GPs practising in these
centres, which were randomized in pairs to control (standard care) or intervention (care guided by implementation
of HURT). We assessed responsiveness of HURT to clinical change by comparing base-line responses to HURT
questions 1-6 with those at follow up. We assessed clinical utility by comparing outcomes between control and
intervention pairs after 3 months, using locally-developed 5-point verbal-rating scales: the patient-satisfaction scale
(PSS) and doctor-satisfaction scale (DSS).
Results: For test-retest reliability in 40 patients, intra-class correlation coefficients were 0.66-0.78 for questions 1-4
and 0.90-0.93 for questions 5-7 (all P ≤ 0.001). For the dichotomous response to question 8, Kappa coefficient = 1
(P < 0.0001). Internal consistency was good (Cronbach’s alpha = 0.74). In 342 patients, HURT signalled clinical
improvement over 3 months through statistically significant changes in responses to questions 1-6. PSS scores
were higher among those in whom HURT recorded improvement, and also higher among those with less severe
headache at baseline. Patients treated with guidance from HURT (n = 207) were more satisfied than controls
(n = 135), but this did not quite reach statistical significance (P = 0.06).
Conclusion: The Arabic HURT Questionnaire is reliable and responsive to clinical change in Arabic-speaking
headache patients in primary care. HURT showed clinical utility in this first assessment, conducted in parallel with
studies elsewhere in other languages, but this needs further study. Other Arabic instruments are not available as
standards for comparison.
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It is well established that headache causes substantial
disability worldwide [1] and is among the most com-
monly reported neurological disorders in primary care
[2]. Because of their high prevalence and their disab-
ling nature, tension-type headache (TTH), migraine
and medication-overuse headache (MOH) are three
disorders collectively responsible for the majority of
headache-attributed burden [3-7].
In collaboration with the World Health Organization
(WHO), the Global Campaign against Headache was
launched by the non-governmental organization Lifting
The Burden (LTB) in 2004 [8,9]. It has made progress
since towards its objective of reducing the burden of
headache worldwide [10]. LTB expressly recognizes
that, because of the numbers of people affected, most
headache disorders need to be managed in primary
care [8], and accordingly has produced a range of man-
agement aids for use by non-specialist health-care
providers (HCPs) [11]. These include an outcome meas-
ure, the HURT (Headache Under-Response to Treatment)
questionnaire [12-14], an 8-item, self-administered
questionnaire addressing headache frequency, disabil-
ity, medication use and effect, perception of headache
“control” and knowledge of diagnosis (see Additional
file 1). The original instrument was created in English
by an expert consensus group drawn from all six world
regions, and including patients’ representatives, and
refined through a multi-stage process consisting of
item development, item reduction using item-response
theory, and psychometric testing [12,13]. The first
seven questions each have five categorical response
options, graded from good to bad. Question 8 is di-
chotomous (yes/no). Responses are numerically coded,
and can be summed, but questions address heteroge-
neous concepts related to care and outcome and pro-
vide greater information when analyzed separately.
Specifically, while being designed as an outcome meas-
ure, HURT aims to guide management not only by in-
dicating when treatment is or is not optimal but also
by suggesting how management should be modified to
improve outcome. This feature links the assessment to
clinical advice and decision making in a way expected
to be of particular help in primary care. Specifically
how this is achieved can be seen from the instructions
attached to HURT (Additional file 1).
In its original English version, HURT has been shown
to be reliable, to function similarly across different
headache disorders and to correlate well and in the
expected directions with other validated measures
(e.g., The Migraine Disability Assessment [MIDAS]
questionnaire, the Headache Impact Test [HIT-6], the
depression scale of the Patient Health Questionnaire
[PHQ-9], health-related quality of life measure [HRQoLv2] and the Migraine Prevention Questionnaire [MPQ])
[12-14]. Psychometric validation of HURT is continu-
ing. However, the purpose of drawing the formulating
group from all world regions was to develop an instru-
ment useful not only for all primary headache disorders
but also cross-culturally. Test-retest reliability has been
evaluated in headache specialist centres in Denmark,
Italy and the United Kingdom [15], and assessments
of clinical utility are being undertaken in multiple
languages and countries. This study begins these
processes for an Arabic version of HURT: more than
320 million people, and possibly 60 million with
troublesome headache, are native Arabic speakers. We
asked whether the Arabic version of HURT is reliable,
responsive as an outcome measure in clinical practice
and helpful to management by primary-care physicians
(PCPs).
We were constrained by a lack of alternative instru-
ments validated in the Arabic language or Saudi
Arabian population that we might use as standards. To
assess outcome, we applied simple locally-developed
satisfaction scores.
Methods
This prospective study was carried out in two stages in
Riyadh City, Kingdom of Saudi Arabia.
Ethics approval
The Institutional Review Board of National Guard
Health Affairs, Saudi Arabia, approved the study.
Translation
Translation into Arabic followed the very rigorous
translation protocol developed by LTB [16] to achieve
linguistic and conceptual equivalence between the
Arabic and original English versions. In summary, two
independent forward-translations by two Arabic native
speakers fluent in English, one a headache expert (MJ),
were reconciled through a translation coordinator.
Back-translation was carried out by another bilingual
headache expert, and the product compared with the
original for equivalence, with further reconciliation as
needed. A lay native Arabic speaker assessed the ag-
reed translation for comprehensibility, and finally this
was tested on 10 headache patients. Full details of
these procedures are published elsewhere [16].
Study participants
The study was conducted in four primary-care centres
serving Saudi National Guard employees and their
families in the city of Riyadh, which is reasonably rep-
resentative of the Saudi population: relatively young,
genetically homogeneous and with almost equal gender
representation. Each centre had its own staff, and PCPs
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visiting any of these centres were included if com-
plaining of headache, diagnosed by their PCP as having
migraine, TTH or MOH, older than 18 years, Arabic-
speaking and giving informed consent. Patients with
trigeminal autonomic cephalalgias, secondary head-
ache other than MOH, dementia or major psychiatric
disorder (all psychoses and major depression) were
excluded. The treating PCPs were responsible for ap-
plying the study inclusion and exclusion criteria.
All PCPs from the four centres attended a one-day
workshop on the diagnosis and management of head-
ache disorders in order to reduce inter-physician vari-
ability in knowledge and practice. Diagnostic work up,
therapeutic interventions and frequency of follow-
up were then left to the discretion of the treating
physicians.
Study design
The study was conducted in two stages from January
2009 to June 2010. Stage one assessed test-retest reliabil-
ity and internal consistency. Patients answered all eight
questions of HURT at their first (baseline) visits, and
again at their second visits 4-6 weeks later, meanwhile
receiving usual care.
Stage two had two purposes: first to assess the respon-
siveness of HURT to clinical change (reflecting its utility
as an outcome measure) and second to examine its clin-
ical utility in guiding PCPs’ management of headache
disorders. After a review of their patterns of headache
presentation and the numbers of PCPs in each, the four
centres were paired so as best to eliminate differences
between the pairs. Each had almost 20 PCPs. The two
pairs were then randomly assigned to either intervention
(PCPs using HURT to guide their management of
patients) or control (PCPs continuing their usual prac-
tice). Each centre recruited patients during the following
three months, with the patients of these pairs of centres
in the intervention and control groups respectively.
After six months, the control centres introduced the
HURT Questionnaire into their practice, and their sub-
sequent patients were added to the intervention group.
Outcome measurement
All patients were seen at baseline, when HURT was ap-
plied to those in the intervention group. Effectiveness of
management was assessed after 3 months: patients in
the intervention group again completed HURT, while all
patients answered two questions in a locally-developed
patient-satisfaction scale (PSS) addressing headache fre-
quency and control, and its effect on life. The response
options to each, in a 5-point verbal-rating scale, were:
very satisfied, satisfied, neither satisfied nor dissatisfied,
dissatisfied, very dissatisfied. All treating PCPs answeredtwo questions in a similar doctor-satisfaction scale
(DSS), with the same response options, addressing diag-
nosis and management/control. The verbal responses
were given numerical scores from +2 (very satisfied) to -
2 (very dissatisfied). It was assumed that higher scores
on these scales reflected better outcomes and better
clinical management.
HURT responsiveness to clinical change was assessed
in the intervention group (ultimately all patients) by
comparing patients’ responses to questions 1-6 at first
visit with those at the follow-up visit.
Statistical analyses
Data were analyzed using Statistical Analysis Software
(SAS) version 9.0. Student’s t-test and the chi-squared
test were used to compare means and proportions re-
spectively. Logistic regression analysis was carried out to
identify predictors of satisfaction. The model included
age, gender, level of education, marital status and use of
HURT. Results were expressed as odds ratios (ORs) with
95% confidence interval (CI).
The various questions of HURT address heterogeneous
concepts related to care and outcome, so greater infor-
mation is provided when each is analyzed separately. We
used the numerical codes assigned by HURT to the five
response options to each of questions 1-7 (from 1 [most
favourable] to 5 [least favourable]), and treated these as
continuous variables, which we summarized by means
and standard deviations (SDs). Reliability and internal
consistency in these questions were assessed by intra-
class correlation coefficient and Cronbach’s alpha re-
spectively. For question 8, the dichotomous (yes/no) re-
sponse options were scored yes = 1 and no = 0, and
reliability was assessed by Kappa coefficient.
PSS and DSS numerical scores (derived as above) were
analyzed as continuous variables and summarized by
means and SDs. In addition, they were dichotomized to
“satisfied” (score >0) and “dissatisfied” (score ≤0).
We took patient satisfaction (or lack of it) as the
standard indicator of good (or bad) outcome. After the
follow-up visit, patients in the intervention group were
divided into two categories, “improved” and “worsened”,
on each individual HURT question 1-4 (these four ques-
tions reflecting headache frequency, headache-attributed
disability, and medication use). A patient was catego-
rized as worsened when the difference between visits
(follow-up minus first) was ≤0 (i.e., including no change),
and otherwise (difference >0) as improved. For example,
on HURT question 1 (“on how many days in the last
month did you have a headache?”), a patient answering
“3-5” at both first and follow-up visits would be
considered as worsened, since no benefit was reported
despite treatment, whereas he/she would be considered
improved only when the answer to the same question
Table 2 Responsiveness of HURT questionnaire to clinical
management between first and follow-up visits 3 months
apart (n = 342)
HURT question Response on scale 1-5 mean (SD) P-value
First visit Follow-up visit
1 2.9 (1.0) 2.2 (0.3) <0.0001
2 2.3 (1.0) 1.8 (0.7) <0.0001
3 2.4 (1.1) 1.8 (0.7) <0.0001
Score (Q1 + Q2 + Q3) 7.7 (2.6) 5.8 (2.0) <0.0001
4 2.5 (1.1) 1.8 (0.8) <0.0001
5 2.8 (1.2) 2.3 (0.9) <0.0001
6 2.9 (1.1) 2.6 (0.9) <0.0001
Score (Q5 + 6) 5.6 (2.0) 4.9 (1.6) <0.0001
7 3.0 (1.3) 3.3 (1.1) 0.0007
8 Patients responding “yes” n (%)
82 (40.6%) 109 (54.0%) <0.0001
Reductions indicate improvement, except for question 8.
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scores within each category.
In a second analysis, aimed at showing that PSS scores
meaningfully reflected clinical outcome, we related these
scores to baseline headache severity. HURT grades the
responses to questions 1-4 into four categories of sever-
ity (see Additional file 1); we dichotomized these, for
each question, into “severe headache” (either of the two
highest-severity categories) or otherwise “mild-to-mod-
erate headache”. We then assessed PSS scores in each of
these groupings.
For analysis of clinical utility, HURT was used only as
the intervention; outcome measurements in intervention
and control groups relied on PSS and DSS.
Results
A total of 342 patients (27% male) were recruited, with
mean age 34.8 (±11) years. The first 40 patients
participated in the assessment of test-retest reliability.
Intra-class correlation coefficient for HURT questions
1-7 ranged from 0.66 to 0.93, with highly significant
P-values in each case (Table 1). For question 8, kappa =
1 (P < 0.0001). For internal consistency, Cronbach’s
alpha = 0.74.
Responsiveness of HURT was assessed in all 342
patients. Responses to all questions but one showed
statistically significant improvement at follow up; res-
ponses to question 7 (“Do you feel in control of your
headaches?”) showed statistically significant worsening
(Table 2). In a question-by-question analysis for ques-
tions 1-4, patients who improved according to HURT
had higher PSS scores (more satisfied) (Table 3).
Patients who had mild-to-moderate headache at base-
line were more satisfied at the follow-up visit (Table 4).
As for clinical utility of HURT, the demographics of
the intervention (n = 207) and control (n = 135) groups
showed small but significant mismatches in gender dis-
tribution and educational level (Table 5). Patients were
more satisfied in the intervention group (i.e., those inTable 1 Correlations between test and retest responses 4-6 w
HURT question
1. On how many days in the last month did you have a headache?
2. On how many days in the last three months did your headaches make it h
out household work?
3. On how many days in the last three months did your headaches spoil or p
leisure activities?
4. On how many days in the last month did you take medication to relieve a
5. When you take your headache medication, does one dose get rid of your
6. Do you feel in control of your headaches?
7. Do you avoid or delay taking your headache medication because you do
8. Do you feel you understand [your headache] diagnosis?whom management was guided by HURT), but this did
not quite reach statistical significance (0.52 vs 0.41; P =
0.06). There was no difference in DSS between PCPs
who did and those who did not use HURT (0.77 vs 0.74;
P = 0.57).
Logistic regression analysis found female gender was
the only significant predictor of patient satisfaction:
women were more likely to be satisfied (OR = 2.0; 95%
CI: 1.2-3.1; P = 0.003).
Discussion
Our study was the first to translate and test the HURT
Questionnaire in clinical use in an Arab population. It
showed that HURT in Arabic language and applied to a
population of Arabic-speaking headache patients in pri-
mary care is a reliable instrument. The 4-6-week period
between test and retest balanced potential recollection
bias (retest being influenced by the patients’ possible
recollections of his or her previous responses) against
the likelihood of real change in the disease during theeeks apart to HURT questions 1-8 (n = 40)
Intra-class correlation
coefficient
P-value
0.74 <0.0001
ard to work, study or carry 0.66 0.001
revent your family, social or 0.78 <0.0001
headache? 0.67 <0.0001
headache and keep it away? 0.92 <0.0001
0.90 <0.0001
not like its side-effects? 0.93 <0.0001
Kappa = 1.00 <0.0001
Table 3 Improvement as indicated by individual HURT
questions (follow-up vs first visits) is associated with
higher Patient Satisfaction Scores (PSS) at follow-up visit
Mean PSS (SD)
HURT
question
Patients who
improved
Patients who
worsened
P-value
1 0.91 (1.71) (n = 127) -0.41 (2.16) (n = 79) <0.0001
2 1.18 (1.74) (n = 92) -0.20 (1.98) (n = 155) <0.0001
3 1.22 (1.67) (n = 90) -0.19 (2.02) (n = 115) <0.0001
4 0.95 (1.81) (n = 107) -0.16 (2.04) (n = 100) <0.0001
Table 5 Demographic characteristics of the control and
the intervention groups
Control
n = 135
Intervention
n = 207
P-value
Age (years) (mean ±
SD)
34.8 ± 11.07 34.2 ± 12.3 0.60
Male (n [%]) 48 [35.6] 43 [20.8] 0.003
Married (n [%]) 99 [75.0] 162 [79.0] 0.39
University education
(n [%])
23 [17.0] 15 [7.2] 0.005
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significant correlations (ranging from 0.66 to 0.78).
These are acceptable, and at levels expected for this type
of instrument, for questions that require recall of
symptoms and medication use over the preceding 1-3
months [17,18]. For questions 5-7, excellent correla-
tions were noted (ranging from 0.90 to 0.93) [17,18].
This reflects the more opinion-based nature of these
questions and their relationship to present time ra-
ther than being recall-dependent. Internal consistency
(Cronbach’s alpha = 0.74) was also acceptable.
We have also shown that HURT, in Arabic, is respon-
sive as an outcome measure. Although the clinical
change between baseline and follow-up visits was not
quantified (no “gold-standard” measure exists), it was
probably real for two reasons. First, most change was to-
ward improvement, which must be expected after 3
months of medical treatment. Second, patients in whom
HURT questions 1-4 signalled improvement reported
satisfaction (positive PSS scores), while those in whom
HURT signalled worsening (or no improvement)
reported dissatisfaction (negative PSS scores). The op-
posite direction of change in the responses to question 7
was unexpected, but it might, perhaps, be explained.
This question addresses patients’ feelings about head-
ache control in general, and may have been interpreted
in different ways. Some patients may have understood it
to be asking about a “cure” for their condition, rather
than effective management or control. It may well beTable 4 Baseline headache severity as measured by
individual HURT questions is inversely related to Patient
Satisfaction Scores (PSS) at follow-up
Mean PSS (SD)
HURT
question
Patients with mild-to-
moderate headache at
first visit
Patients with
severe headache at
first visit
P-value
1 0.58 (1.91) (n = 191) -1.73 (1.94) (n = 15) <0.0001
2 0.70 (1.89) (n = 175) -1.13 (1.91) (n = 32) <0.0001
3 0.67 (1.90) (n = 177) -1.07 (1.95) (n = 30) <0.0001
4 0.72 (1.90) (n = 172) -1.06 (1.83) (n = 35) <0.0001that (some) patients’ expectations were unduly high and
consequently unmet, or, very possibly, that 3 months
was not sufficient to engender a feeling of control.
Validation of an outcome measure against expressions
of patients’ satisfaction is methodologically debatable.
We chose this approach for two reasons. First, there is
no other outcome measure validated for Saudi Arabian
culture. This was decisive on its own, but, second,
patients’ satisfaction is of itself an important aspect of
outcome. The drawback is that patients’ satisfaction has
many determinants. It would be out-of-place here to dis-
cuss the large literature on this (none of it related to a
Saudi population). However, while change in the disease
itself is of course among these determinants, so, and im-
portantly, is change in the way patients cope with and
perceive their disease. The latter is highly subject to
prior expectation, which may or may not be reasonable
(either too high or too low). Nevertheless, the clear cor-
relation, in the expected direction, between patients’ sat-
isfaction and change as quantified by HURT strongly
suggests that HURT detected and measured real change.
Whether change was due solely to standard care or
improvement was enhanced by PCPs’ use of HURT is
not absolutely clear: we found only a strong trend (P =
0.06) towards greater satisfaction in patients in the inter-
vention (HURT) group compared with those in the con-
trol (standard care) group. Although the PSS was locally
developed and itself not previously validated, we believe
we showed here that PSS scores were an indicator, gen-
erally, of good outcome. But, for the reasons given
above, patients’ satisfaction may be neither sensitive nor
specific enough to reflect any effect of an intervention
of this sort. DSS scores showed no difference between
groups. The DSS was also locally developed and unvalid-
ated. Doctors’ satisfaction has different determinants:
it is likely of course to be increased by improved out-
comes, but it may also be decreased by use of an out-
come measure that indicates outcomes could be better
(as HURT is intended to do). To establish the clinical
utility of HURT as a management aid needs further
study, but the lack of a gold-standard outcome measure
(a gap that HURT was designed to fill) remains as an
impediment to such study.
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reasons, we randomized physicians rather than patients.
Although all physicians received similar training, out-
come differences between groups could in part have
reflected differences in practice. Any such influence was
partially offset by switching the two control centres to
intervention, applying HURT, during the last six months
of the study. Although this introduced the possibility of
a period effect, it was unlikely that this was large or sig-
nificant, and anyway it was diluted. We do not believe
the minor differences between control and intervention
groups in gender and level of education (Table 5) would
have had significant impact on the comparison.
Conclusion
The HURT Questionnaire in the Arabic language is a re-
liable and responsive outcome measure in an Arabic-
speaking population of headache patients in primary
care. It detects change in illness over time, but its clin-
ical usefulness as an aid to management needs further
study.
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